BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 30981208)

  • 21. Role of Metabolism in the Immunobiology of Regulatory T Cells.
    Galgani M; De Rosa V; La Cava A; Matarese G
    J Immunol; 2016 Oct; 197(7):2567-75. PubMed ID: 27638939
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comment on "cutting edge: epigenetic regulation of Foxp3 defines a stable population of CD4+ regulatory T cells in tumors from mice and humans".
    Huehn J; Floess S; Ohkura N; Sakaguchi S
    J Immunol; 2015 Apr; 194(8):3533. PubMed ID: 25848068
    [No Abstract]   [Full Text] [Related]  

  • 23. Vaccination against Foxp3(+) regulatory T cells aggravates atherosclerosis.
    van Es T; van Puijvelde GH; Foks AC; Habets KL; Bot I; Gilboa E; Van Berkel TJ; Kuiper J
    Atherosclerosis; 2010 Mar; 209(1):74-80. PubMed ID: 19765709
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Response to comment on "cutting edge: epigenetic regulation of Foxp3 defines a stable population of CD4+ regulatory T cells in tumors from mice and humans".
    Waight JD; Hofmeister R; Wilson NS
    J Immunol; 2015 Apr; 194(8):3533-4. PubMed ID: 25848069
    [No Abstract]   [Full Text] [Related]  

  • 25. Sensitive detection of Foxp3 expression in bovine lymphocytes by flow cytometry.
    Gerner W; Stadler M; Hammer SE; Klein D; Saalmüller A
    Vet Immunol Immunopathol; 2010 Nov; 138(1-2):154-8. PubMed ID: 20701981
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IPEX and the role of Foxp3 in the development and function of human Tregs.
    Le Bras S; Geha RS
    J Clin Invest; 2006 Jun; 116(6):1473-5. PubMed ID: 16741571
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acceleratory effects of ambient fine particulate matter on the development and progression of atherosclerosis in apolipoprotein E knockout mice by down-regulating CD4
    Wan Q; Liu Z; Yang M; Wu J
    Toxicol Lett; 2019 Nov; 316():27-34. PubMed ID: 31513887
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impaired T cell receptor signaling in Foxp3+ CD4 T cells.
    Carson BD; Ziegler SF
    Ann N Y Acad Sci; 2007 Apr; 1103():167-78. PubMed ID: 17376831
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IL-2 contributes to maintaining a balance between CD4+Foxp3+ regulatory T cells and effector CD4+ T cells required for immune control of blood-stage malaria infection.
    Berretta F; St-Pierre J; Piccirillo CA; Stevenson MM
    J Immunol; 2011 Apr; 186(8):4862-71. PubMed ID: 21389253
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structural aspects of the FOXP3 regulatory complex as an immunopharmacological target.
    Zhou Z; Song X; Berezov A; Li B; Greene MI
    Int Immunopharmacol; 2009 May; 9(5):518-20. PubMed ID: 19539569
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pillars Article: Foxp3 Programs the Development and Function of CD4+CD25+ Regulatory T Cells. Nat. Immunol. 2003. 4: 330-336.
    Fontenot JD; Gavin MA; Rudensky AY
    J Immunol; 2017 Feb; 198(3):986-992. PubMed ID: 28115587
    [No Abstract]   [Full Text] [Related]  

  • 32. Foxp3 is required throughout the life of a regulatory T cell.
    Lopes JE; Soper DM; Ziegler SF
    Sci STKE; 2007 Jul; 2007(393):pe36. PubMed ID: 17609478
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transcriptional regulation of Foxp3 in regulatory T cells.
    Haiqi H; Yong Z; Yi L
    Immunobiology; 2011 Jun; 216(6):678-85. PubMed ID: 21122941
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The regulatory T cell-associated transcription factor FoxP3 is expressed by tumor cells.
    Ebert LM; Tan BS; Browning J; Svobodova S; Russell SE; Kirkpatrick N; Gedye C; Moss D; Ng SP; MacGregor D; Davis ID; Cebon J; Chen W
    Cancer Res; 2008 Apr; 68(8):3001-9. PubMed ID: 18413770
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comment on "Cutting edge: depletion of Foxp3+ cells leads to induction of autoimmunity by specific ablation of regulatory T cells in genetically targeted mice".
    Wolf D; Wolf AM; Tzankov A
    J Immunol; 2010 Apr; 184(8):4051. PubMed ID: 20368283
    [No Abstract]   [Full Text] [Related]  

  • 36. The role of FOXP3 in autoimmunity.
    Pesenacker AM; Cook L; Levings MK
    Curr Opin Immunol; 2016 Dec; 43():16-23. PubMed ID: 27544816
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nonoverlapping roles of PD-1 and FoxP3 in maintaining immune tolerance in a novel autoimmune pancreatitis mouse model.
    Zhang B; Chikuma S; Hori S; Fagarasan S; Honjo T
    Proc Natl Acad Sci U S A; 2016 Jul; 113(30):8490-5. PubMed ID: 27410049
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Decreased expression of EBI3 and Foxp3 in CD4+CD25+ regulatory T cells in murine experimental allergic rhinitis.
    Ouyang Y; Nakao A; Fan E; Li Y; Zhao L; Zhang W; Han D; Zhang L
    ORL J Otorhinolaryngol Relat Spec; 2011; 73(6):313-20. PubMed ID: 21986066
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Depleting regulatory T cells with arginine-rich, cell-penetrating, peptide-conjugated morpholino oligomer targeting FOXP3 inhibits regulatory T-cell function.
    Morse MA; Hobeika A; Serra D; Aird K; McKinney M; Aldrich A; Clay T; Mourich D; Lyerly HK; Iversen PL; Devi GR
    Cancer Gene Ther; 2012 Jan; 19(1):30-7. PubMed ID: 21997230
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased CD4
    Ma YH; Zhang J; Chen X; Xie YF; Pang YH; Liu XJ
    World J Gastroenterol; 2016 Nov; 22(42):9356-9367. PubMed ID: 27895423
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.